Telix Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-06-30 | 2023-12-31 |
|---|---|---|---|
Revenue | $594,244 | $188,963 | $281,713 |
Gross Profit | 385,797 | 123,881 | 223,975 |
EBITDA | 76,800 | 15,747 | 23,714 |
EBIT | 78,795 | 13,752 | 20,075 |
Net Income | 38,239 | 11,680 | 19,531 |
Net Change In Cash | 594,244 | 188,963 | 281,713 |
Free Cash Flow | -10,916 | 19,913 | 2,840 |
Cash | 710,346 | 118,837 | 123,237 |
Basic Shares | 345,188 | 350,750 | 323,727 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $783,207 | $502,547 | $160,096 | $7,596 |
Gross Profit | 509,678 | 314,390 | 29,337 | -29,765 |
EBITDA | 92,547 | 22,966 | -92,837 | -70,073 |
EBIT | 82,130 | 16,223 | -98,216 | -75,247 |
Net Income | 49,919 | 5,211 | -104,079 | -80,510 |
Net Change In Cash | 783,207 | 502,547 | 160,096 | 7,596 |
Free Cash Flow | 8,997 | 13,090 | -77,831 | -60,667 |
Cash | 710,346 | 123,237 | 116,329 | 22,037 |
Basic Shares | 345,188 | 323,710 | 310,644 | 282,206 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | $0.01 |
2025-03-31 | $0.09 |
2024-12-31 | $0.06 |
